Abstract: Isolated antibodies have been characterized which show specific affinity to a repeating conformational epitope of a protofibril form of the human ?-amyloid peptide as compare to low molecular weight forms of ?-amyloid peptide. These isolated antibodies and related pharmaceutically effective compositions may be useful in the therapeutic and/or prophylactic treatment of Alzheimer's disease by effectively blocking the ability of the protofibril form of ?-amyloid peptide to form fibril forms linked with complications associated with Alzheimer's disease. The isolated antibodies of the present invention are also useful in various diagnostic assays and associated kits.

Abstract: Isolated monoclonal antibodies are disclosed herein that specifically bind endoplasmin. In some embodiments these antibodies are fully human. Recombinant nucleic acids encoding these antibodies, expression vectors including these nucleic acids, and host cells transformed with these expression vectors are also disclosed herein. In several embodiments the disclosed antibodies are of use for detecting and/or treating tumors that express endoplasmin, such as melanoma, breast cancer, head and neck squamous cell carcinoma, renal cancer, lung cancer, glioma, bladder cancer, ovarian cancer or pancreatic cancer. In one example, the tumor is a melanoma.

Abstract: The present invention relates to a method of treating a disease or disorder in a patient comprising administering, to a patient in need of such treatment, an antibody which binds specifically to human angiopoietin-2 (ANG-2), wherein said antibody comprises: (A) a heavy chain variable domain which comprises a CDR3 region of SEQ ID NO: 1, a CDR2 region of SEQ ID NO: 2 and a CDR1 region of SEQ ID NO: 3; (B) a light chain variable domain which comprises a CDR3 region of SEQ ID NO: 4, a CDR2 region of SEQ ID NO: 5 and a CDR1 region of SEQ ID NO: 6.

Abstract: The invention concerns anti-NGF antibodies (such as anti-NGF antagonist antibodies), and polynucleotides encoding the same. The invention further concerns use of such antibodies and/or polynucleotides in the treatment and/or prevention of pain, including post-surgical pain, rheumatoid arthritis pain, and osteoarthritis pain.

Abstract: The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.

Abstract: The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.

Abstract: An anti-IL-6 antibody, including isolated nucleic acids that encode at least one anti-IL-6 antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.

Abstract: The invention features methods for preventing or treating CGRP associated disorders such as vasomotor symptoms, including headaches (e.g., migraine, cluster headache, and tension headache) and hot flushes, by administering an anti-CGRP antagonist antibody. Antagonist antibody G1 and antibodies derived from G1 directed to CGRP are also described.

Abstract: An objective of the present invention is to decrease the immunogenicity of mouse-derived anti-AXL antibodies in humans by humanizing them. The present invention provides antibodies that can bind to a specific region in Anexelekto (AXL) and humanized antibodies that are produced based on such antibodies. The anti-AXL antibodies of the present invention have high antitumor activity, and are useful as agents for decreasing the AXL expression level, antitumor agents, and diagnostic agents for cancer.

Abstract: The present invention provides a self assembly molecule having an affinity for one or more target molecules, for use in formation of a heptameric complex, comprising: a) a monomer comprising a multimerization domain of Archaeal Sm1 (AF-Sm1) protein or SM-like ribonucleoprotein from other organisms, able to interact with other molecules of the same monomer comprising a multimerization domain of AF-Sm1 protein or SM-like ribonucleoprotein to self-assemble into a heptamer; and b) a target binding domain or peptide attached directly or via a linker to the monomer of (a). Also provided are heptamers comprising these self assembly molecules and methods for their use in therapy, imaging and diagnostics.

Abstract: The present invention relates generally to the field of generating fusion proteins to be used in cancer therapy, and more specifically, to nucleotide sequences encoding the fusion proteins, wherein the chimeric fusion proteins comprises at least one targeting moiety and at least one immunomodulatory moiety that counteracts the immune tolerance of cancer cells.

Abstract: The present disclosure provides proteins comprising antigen binding sites of antibodies that bind to interleukin-11 (IL-11) receptor alpha (IL-11R?) and uses thereof, e.g., in therapy.

Abstract: The present disclosure relates to compositions of daclizumab suitable for subcutaneous administration and methods of manufacturing thereof.

Abstract: The present invention relates to antibodies that specifically bind to the BAFF receptor (BAFFR). The invention more specifically relates to specific antibodies that are BAFFR antagonists with in vivo B cell depleting activity and compositions and methods of use for said antibodies to treat pathological disorders that can be treated by killing or depleting B cells, such as systemic lupus erythematosus or rheumatoid arthritis or other autoimmune diseases or lymphomas, leukemias and myelomas.

Abstract: The present invention relates to a binding molecule which is at least bispecific comprising a first and a second binding domain, wherein the first binding domain is capable of binding to epitope cluster 3 of BCMA, and the second binding domain is capable of binding to the T cell CD3 receptor complex. Moreover, the invention provides a nucleic acid sequence encoding the binding molecule, a vector comprising said nucleic acid sequence and a host cell transformed or transfected with said vector. Furthermore, the invention provides a process for the production of the binding molecule of the invention, a medical use of said binding molecule and a kit comprising said binding molecule.

Abstract: The present invention relates to a synthetic immunogen represented by the general formula 1, useful for generating long lasting protective immunity against various intracellular pathogens which are the causative agents of tuberculosis, leishmaniasis, AIDS, trypanosomiasis, malaria and also allergy, cancer and a process for the preparation thereof. The developed immunogen is able to circumvent HLA restriction in humans and livestock. The invention further relates to a vaccine comprising the said immunogen for generating enduring protective immunity against various diseases. The said vaccine is targeted against intracellular pathogens, more particularly the pathogen M. tuberculosis in this case. In the present invention, promiscuous peptides of M. tuberculosis are conjugated to TLR ligands especially; Pam2Cys to target them mainly to dendritic cells and therefore elicit long-lasting protective immunity. wherein, X1=a promiscuous CD4 T helper epitope selected from SEQ ID No.

Abstract: Digestion of cellulosic biomass solids can be enhanced in the presence of a phenolic solvent. Methods for digesting cellulosic biomass solids can comprise providing cellulosic biomass solids in a digestion medium comprising a phenolic solvent; and heating the cellulosic biomass solids and the digestion medium in a digestion unit in the presence of molecular hydrogen and a slurry catalyst capable of activating molecular hydrogen, thereby forming an alcoholic component derived from the cellulosic biomass solids and liberating lignin from the cellulosic biomass solids into the digestion medium. The methods can further comprise converting at least a portion of the lignin into a phenolic solvent and returning the phenolic solvent formed from lignin to the cellulosic biomass solids.

Abstract: A particulate cellulose derivative is obtained in a process of grinding and drying a moist cellulose derivative which comprises the steps of A) providing a cellulose derivative having a moisture content of from 60 to 95 percent, based on the total weight of the moist cellulose derivative; B) grinding and partially drying the moist cellulose derivative in a gas-swept impact mill; C) contacting the ground and partially dried cellulose derivative with an additional amount of a drying gas outside the gas-swept impact mill; and D) subjecting the cellulose derivative to partial depolymerization after having contacted the cellulose derivative with a drying gas in step C). The obtained particulate cellulose derivative has a high untapped bulk density, a good flowability and a low color intensity.

Abstract: A cellulose resin produced by binding cardanol or a derivative thereof, and a flexible component to cellulose or a derivative thereof.

Abstract: The invention relates to a tire comprising at least one rubber composition based on at least one diene elastomer, one reinforcing filler, one chemical crosslinking agent and one modifying agent, chosen from the compounds of following formula (I): where R denotes a unit comprising at least one reactive group, R1 denotes hydrogen, R2 denotes an alkylene radical comprising from 2 to 8 carbon atoms and optionally one or more heteroatoms chosen from S, N, O or Si, A denotes an oxygen or sulphur atom or an ?NH group, preferably an oxygen atom.

Abstract: A reactor system containing one or more loop reactors for olefin polymerization is provided. The loop reactors include vertical sections, elbow sections, and/or horizontal sections connected into one or more loop reaction zones to polymerize an olefin monomer in the presence of a liquid diluent into a slurry comprising particles of a polyolefin polymer. The reactor system footprint is reduced to increase production efficiency and save cost, while maintaining a high processing capacity. In one embodiment a horizontal length (LH) of at least one horizontal section is greatly reduced with maintained processing capacity. In another embodiment, at least one elbow section of the reactor system is configured to maintain a Dean number (Dn) of the slurry flowing therein to be higher than 3,000,000.

Abstract: To provide a process for producing an olefin polymer, which makes it possible to use, as a solvent for use in the catalyst preparation and the like, an aliphatic hydrocarbon solvent instead of an aromatic hydrocarbon solvent causing large environmental burden, and which has good olefin polymerization activity. A process for producing an olefin polymer, characterized by having a step comprising feeding an olefin polymerization catalyst solution, which is obtained by mixing a metallocene compound, a compound that reacts with the metallocene compound to form an ion pair and at least one compound selected from an organoaluminum compound and an organoaluminum oxy compound with a saturated hydrocarbon solvent, to a polymerization reactor and solution-polymerizing an olefin in the polymerization reactor.

Abstract: A technique for polymerizing ethylene on catalyst in a first polymerization reactor and in a second polymerization reactor to form polyethylene particles, and controlling particle size of the polyethylene particles.

Abstract: A solid polymethylaluminoxane composition is provided having uniform particle diameter in the form of fine particles of less than 5 ?m employed to polymerize olefins with high polymerization activity without silica. A method for manufacturing thereof, a polymerization catalyst, and a method for manufacturing a polyolefin are also provided. The solid polymethylaluminoxane composition: has an aluminum content within a range of 36 mass % to 43 mass %; has a mole fraction of methyl groups derived from trimethylaluminum moieties relative to the total number of mols of methyl groups of 12 mol % or less; and is particulate having a median diameter based on volume within a range of 0.1 ?m to less than 5 ?m. In a step of heating an aromatic hydrocarbon solution containing trimethylaluminum and the polymethylaluminoxane to cause solid polymethylaluminoxane composition to precipitate, prior to or during the heat treating step, a dry, inert gas is bubbled through.

Abstract: A process for preparing a polyethylene resin having a multimodal molecular weight distribution in at least two loop slurry reactors connected in series can include polymerizing ethylene in the presence of at least one supported metallocene catalyst, a diluent, optionally one or more co-monomers, and optionally hydrogen, thereby obtaining the polyethylene resin. The supported metallocene catalyst can have a particle size distribution of a span value lower than 2.5 and a D50 value within the range of from 5 ?m to 20 ?m.

Abstract: A process for producing a fluorinated copolymer includes polymerizing a fluorinated monomer having a carboxylic acid functional group or a sulfonic acid functional group and tetrafluoroethylene by a solution polymerization method in a polymerization medium in the presence of a polymerization initiator to obtain a mixture. The mixture contains a fluorinated copolymer, an unreacted fluorinated monomer having the carboxylic acid functional group or the sulfonic acid functional group, and the polymerization medium. The mixture is continuously or intermittently transferred to an evaporation container equipped with a stirring machine and heated in the evaporation container with stirring to evaporate and recover a mixed liquid. The mixed liquid contains the unreacted fluorinated monomer and the polymerization medium with which the polymerization initiator is mixed. The recovered mixed liquid is heated to decompose the polymerization initiator.

Abstract: Provided is a treatment method for fluororesin pellets to remove hydrofluoric acid released from fluororesin pellets obtained by melt-molding a melt-moldable fluororesin. The treatment method comprises bringing a hydrofluoric acid-removing medium selected from warm water of from 30 to 200° C., steam of from 100 to 200° C. and warm wind of from 40 to 200° C. into contact with fluororesin pellets obtained by melt-molding a melt-moldable fluororesin, and thereby treating the fluororesin pellets so that the amount of hydrofluoric acid released per kg of the resulting fluororesin pellets would be at most 5 ?g as determined after the storage of the resulting fluororesin pellets at 35° C. for 15 days.

Abstract: The present invention relates to materials used for aligning liquid crystals of liquid crystal display elements and to a polymer for use in liquid crystal vertical alignment layer used in producing a liquid crystal vertical alignment layer. The polymer for use in a liquid crystal vertical alignment layer includes (a) a moiety that is photochemically isomerizable but not photochemically crosslinked, (b) a moiety that is photochemically crosslinkable, and (c) a moiety that stabilizes a vertical alignment. The polymer can be used to produce a vertical alignment layer that has a liquid crystal alignment property enabling control of alignment at a low UV dose and that offers a large pretilt angle and superior optical stability.

Abstract: The invention provides novel flame-retardant polymers and materials, their synthesis and use. More particularly, the flame-retardant polymers are deoxybenzoin-derived polymers.

Abstract: The invention includes a composition comprising a vinyl sulfone monomer, a thiol monomer and an acrylate monomer. In one embodiment, the thiol monomer reacts with the vinyl sulfone monomer preferentially over the acrylate monomer, and this differential selectivity allows for the control of the architecture of crosslinking polymer network. The invention further includes a composition comprising an electrophilic monomer, a nucleophilic monomer, a nucleophilic catalyst and an acid, wherein the concentrations of the nucleophilic catalyst and acid are selected as to provide a specific induction time for the polymerization reaction of the composition.

Abstract: The present invention relates to an acrylonitrile-styrene-acrylate (ASA) graft copolymer having a core-shell structure, and a method for manufacturing the same, wherein the core of the ASA graft copolymer is a multi-core rubber copolymer in which alkyl acrylate monomers are sequentially polymerized, and the shell is formed by graft-polymerizing a styrene-based monomer and an acrylonitrile-based monomer with the core. The ASA graft copolymer resin is manufactured by the steps of manufacturing the multi-core rubber polymer latex by sequentially polymerizing the alkyl acrylate monomers; and forming a shell layer by graft-polymerizing the styrene-based monomer and the acrylonitrile-based monomer with the multi-core rubber polymer. The ASA resin composition according to the present invention has excellent impact resistance, weather resistance, and dyeability properties.

Abstract: The present invention relates to coating material compositions comprising at least one polyhydroxyl group-containing compound (A), at least one polyisocyanate group-containing compound (B) having free and/or blocked isocyanate groups, and at least one catalyst (D) based on a zinc-amidine complex which is prepared by reaction of 1.0 moles of at least one zinc(II) biscarboxylate with less than 2.0 moles of at least one amidine where R5=hydrogen and R1, R2, R3, and R4 are each identical or different radicals, R1 and R3 being hydrogen or an alkyl radical or an aryl radical, and R2 and R4 being an alkyl radical or an aryl radical.

Abstract: Polyisocyanate-based polymers are formed by curing a reaction mixture containing at least one polyisocyanate and at least one isocyanate-reactive compound having at least two isocyanate-reactive groups in the presence of a bismuth thiophosphoric acid diester salt.

Abstract: A polyol (PL) for polyurethane preparation is disclosed that includes the polyol (a) and the strength-enhancing agent (b), as follows. Polyol (a): a polyoxyalkylene polyol that is the alkylene oxide adduct of an active hydrogen-containing compound (H), in which at least 40% of a hydroxyl group positioned on the terminal is a primary hydroxyl group-containing group represented by general formula (I). In general formula (I), R1 represents a hydrogen atom or an alkyl group having 1 to 12 carbon atoms, cycloalkyl group, or phenyl group. Strength-enhancing agent (b): a compound that is at least one compound selected from the group comprising an ester compound, a thioester compound, a phosphoric acid ester compound, and an amide compound, and that is derived from an aromatic polyvalent carboxylic acid with a valence of 2 or higher.

Abstract: Addition compound suitable as wetting and dispersing agent, obtainable from the reaction of A) polyepoxides with B) at least one primary polyoxyalkyleneamine C) at least one other aliphatic and/or araliphatic primary amine and D) at least one modified isocyanate.

Abstract: This invention relates to a novel curing method of oligomers, using metal triflates, and particularly to the curing of hydroxyl terminated elastomers to achieve crosslinked polymers. The method finds particular use as an alternative cure methodology to replace isocyanate curing. There is further provided a cured and crosslinked polymer binder, which is particularly suitable and compatible for use with energetic materials.

Abstract: A polymer colorant including polymer monomer units, and at least one alizarin unit which is incorporated into the polymer and which provides color to the polymer colorant and a process for preparing the polymer colorant. An article or composition containing the polymer colorant. A toner including the polymer colorant, and optionally, one or more ingredients selected from the group consisting of crystalline polyester resins, amorphous polyester resins, colorants, waxes, coagulants, mordants, and mixtures and combinations thereof. A polymer latex including an aqueous dispersion of polymer colorant, wherein the polymer colorant comprises polymer monomer units and at least one alizarin unit which is incorporated into the polymer and which provides color to the polymer colorant; and optionally, a mordant.

Abstract: A self-sensitive polymerizable liquid resin is provided, which contains an uncrosslinked Michael addition reaction product of the following components: a Michael donor, a Michael accepter and optionally a viscosity modifier. The Michael accepter has 5 to 18 acryloyl functional groups. The self-sensitive polymerizable liquid resin of the present invention is capable of being used as an aid in a coating composition and providing a good property in deep radiation curing, and is particularly applicable in color coatings.

Abstract: The present invention relates to the preparation of modified polymers by incorporating a compositional modifier into a polymer to produce the modified polymer. More particularly, the invention relates the preparation of condensation type copolyesters or copolyamides by joint short length polyester or polyester oligomers or short length polyamide or polyamide oligomers with a modifier which contains hydroxyl acids blocks.

Abstract: A process for purifying a poly(alkylene carbonate), said process comprising the steps of adding said poly(alkylene carbonate) to an aqueous solution, optionally in the presence of an acid compound, in the absence of any organic solvent. subsequently heating said blend to a temperature of up to 200° C.; and removing the aqueous phase and drying the residue.

Abstract: A liquid crystal polyester amide of the present invention includes 10 mol % to 65 mol % of a structural unit represented by the following formula (1), 3 mol % to 17.5 mol % of a structural unit represented by the following formula (2), 5 mol % to 20 mol % of a structural unit represented by the following formula (3), 7.5 mol % to 42 mol % in total of at least one of a structural unit represented by the following formula (4-1) and a structural unit represented by the following formula (4-2), and 2.5 mol % to 40 mol % in total of at least one of a structural unit represented by the following formula (5-1) and a structural unit represented by the following formula (5-2), and has a melting point of 300° C. or higher.

Abstract: A coating material including a perfluorocarbon sulfonic acid resin which is a copolymer including a polymerization unit represented by —(CF2—CFZ)—, in the formula, Z being H, Cl, F, or a C1-C3 perfluoroalkyl group, and a polymerization unit represented by —(CF2—CF(—O—(CF2)m—SO3H))—, in the formula, m being an integer of 1 to 12, and the perfluorocarbon sulfonic acid resin has an equivalent weight EW of 200 to 1000. Also disclosed is a laminate including a base material and a hydrophilic layer formed from the coating material.

Abstract: A polyorganosiloxane resin represented by the following general formula (5): (R3SiO1/2)l?(R2SiO2/2)m?(RSiO3/2)n?(SiO4/2)o? (5) wherein R is, independently of each other, a hydrogen atom or a monovalent hydrocarbon group having 1 to 18 carbon atoms, and optionally having an oxygen, halogen, nitrogen or sulfur atom; l?, m? and o? are, independently of each other, an integer of from 0 to 10,000; n? is an integer of from 1 to 10,000; a total of l?, m? and n? is from 2 to 30,000; and at least one R is a hydrogen atom and at least one R is an —OX group in the molecule, wherein X is an alkyl group having 1 to 10 carbon atoms or an alkoxyalkyl group having 2 to 10 carbon atoms; and at least one hydrogen atom and at least one —OX group bond to one and the same silicon atom.

Abstract: The invention concerns polysiloxane compounds as W/O-emulsifiers, in textile softeners, antifoams, foam stabilizers and agriculture chemicals, in particular as W/O-emulsifiers for cosmetic uses.

Abstract: The present invention provides a method for preparing a sample characterized by binding a substance A containing a hydrazide group to a sugar chain and/or a sugar derivative via hydrazone formation between the hydrazide group of the substance A and the reducing end of the sugar chain and/or the sugar derivative thereby to enable the separation and purification of the sugar chain and/or the sugar derivative for an analytical sample from a biological sample containing the sugar chain and/or the sugar derivative by a simple operation.

Abstract: A cyclic olefin resin film which has heat resistance and improved brittleness. A heat-resistant transparent film which has an internal haze value of 1.0% or less and contains a cyclic olefin resin having a refractive index of n1 and a glass transition temperature (Tg) of 170° C. or more and a styrene elastomer that has a refractive index of n2 so that ?n=|n2?n1| is 0.012 or less. The heat-resistant transparent film may contain two or more kinds of styrene elastomers, and the cyclic olefin resin may be a copolymer of norbornene and ethylene.

Abstract: The method for producing a porous film of the present invention includes producing a stretched film by stretching a resin sheet containing at least polyolefin, and then irradiating the stretched film with a vacuum ultraviolet ray. The separator for a non-aqueous electrolyte battery of the present invention is composed of the porous film obtained by the production method of the present invention. The non-aqueous electrolyte battery of the present invention is provided with the separator for a non-aqueous electrolyte battery of the present invention.

Abstract: Polymeric foams and elastomer/hydrogel bicontinuous composite structures derived from high internal phase emulsions and possessing shape-memory characteristics are disclosed, as well as processes for forming the same and uses thereof in, for example, manufacturing of various articles.

Abstract: There are provided a composition for silicone rubber foam, a manufacturing method of a silicone rubber foam, and a silicone rubber foam in which it is possible to control the foaming states. The composition for silicone rubber foam contains: (A) 100 parts by mass of polyorganosiloxane having a degree of polymerization of 4,000 to 10,000 and having two or more alkenyl groups at a content of 0.001 mmol/g or more and less than 0.3 mmol/g; an amount of polyorganohydrogensiloxane having an average of two or more Si-atom-bonded hydrogen atoms so that a molar ratio of the hydrogen atoms to the alkenyl groups in the (A) component is 0.001 to 5; 0.1 to 10 parts by mass of an organic foaming agent with a decomposition temperature of 50 to 250° C.; 5 to 200 parts by mass of silica powder; and a catalyst amount of a platinum-based metal catalyst activated with ultraviolet rays.

Abstract: A shaped part that is formed from a polymer composition that contains a liquid crystalline polymer and a black pigment is provided. By selectively controlling the type and relative concentration of these components, the polymer composition and shaped parts formed therefrom can have a dark black appearance, and yet still exhibit good thermal and mechanical properties at high temperatures.